Sponsors
The bill boosts transparency, speeds and streamlines NIH SBIR/STTR awards and seeks to improve equity and commercialization outcomes, but does so at the cost of added federal administrative burden, potential short‑term legal and planning uncertainty, and risks to review rigor and program resources.
Small business awardees and researchers at NIH will receive funding faster and face more standardized, simpler NIH SBIR/STTR procedures (including an alternative peer-review pilot), reducing cash‑flow delays and administrative uncertainty for applicants.
Small businesses will gain clearer, public information on agency review-time medians and longer trend reporting, helping them plan submissions and creating incentives for agencies to streamline decision processes.
Underrepresented small businesses (including women and racial/ethnic minorities) and new entrant firms stand to get better-targeted outreach and commercialization support if a GAO study identifies barriers and agency practices to improve SBIR/STTR equity and alignment with agency research priorities, which could also increase returns to taxpayers.
Taxpayers and federal agencies will incur additional administrative costs and burdens from preparing GAO reports, updating regulatory text, aggregating 11 years of review‑time data, and running NIH pilot implementations, which could divert staff time and resources.
Researchers and patients could face risks if faster or alternative NIH peer‑review procedures reduce rigor, potentially lowering award quality and affecting downstream research and patient outcomes.
Small businesses may face short‑term legal uncertainty or litigation risk if statutory wording insertions change legal interpretations unexpectedly.
Based on analysis of 5 sections of legislative text.
Adds GAO reporting on SBIR/STTR diversity and commercialization, expands agency reporting to include review timing, and directs an NIH pilot to shorten award processing toward a ~90-day funding goal.
Introduced August 19, 2025 by Morgan McGarvey · Last progress August 19, 2025
Requires a Government Accountability Office (Comptroller General) report on how well the SBIR and STTR programs diversify participants and promote commercialization, extends and expands an existing SBIR/STTR reporting requirement to include review-timing metrics, and directs the NIH Director to run a pilot to speed up NIH SBIR/STTR award processing with a goal of getting funds released about 90 days after notice of award. It also makes minor wording/punctuation edits to the Small Business Act.